The latest food and beverage industry news and trend analysis

McDonald’s Corporation is actively testing new menu items and adjusting its long-term food strategy to accommodate the rapidly shifting dietary habits of consumers using GLP-1 weight-loss medications, such as Ozempic and Wegovy.

Speaking during the company's fourth-quarter 2025 earnings call, CEO Chris Kempczinski confirmed that the quick-service restaurant (QSR) giant is closely monitoring this demographic, which now accounts for an estimated 10% of the U.S. population.

"As adoption grows, we know that consumers’ behaviour changes," Kempczinski stated, noting a distinct shift away from traditional fast-food consumption patterns toward protein-dense, smaller-portioned meals and a reduction in sugary beverage intake.

Adapting to the 'Appetite Suppressed' Demographic

The rise of GLP-1 drugs has prompted a broader industry recalibration. Competitors across the food landscape, including CPG giants like Conagra Brands and General Mills, as well as fast-casual chains like Shake Shack (with its recent "Good Fit Menu"), have already introduced specialised messaging and high-protein alternatives.

McDonald's is leveraging its existing menu architecture to meet these needs while developing future innovations. Vice President Jill McDonald highlighted that several current items already resonate with this consumer segment, including:

• Snack Wraps (slated for a broader reintroduction)

• McCrispy Strips

• Sausage Biscuit Sandwiches

While specific long-term product pipelines were kept under wraps, leadership confirmed that serving the GLP-1 demographic—characterised by reduced snacking and altered beverage choices—is now a formal component of the company's innovation strategy.

Financial Context: Value Strategy Drives Q4 Beat

The menu pivot comes against the backdrop of a highly successful financial quarter, driven primarily by McDonald's aggressive value positioning. The company beat analyst expectations for Q4 2025, posting:

• Revenue: $6.83 billion

• Earnings Per Share (EPS): $3.05

A critical engine for this growth was the widely publicised $5 Meal Deal, which successfully lured budget-conscious consumers facing elevated grocery costs. This value tier boosted U.S. same-store sales by an impressive 9%, helping to offset broader industry pressures related to menu price inflation and softening demand among lower-income demographics.

Operational Outlook: Aggressive Expansion

Despite macroeconomic headwinds, McDonald's continues to pursue an aggressive global growth mandate. The company reiterated plans to open 2,200 new restaurants, underpinning a dual strategy: capturing value-driven traffic through aggressive promotions while future-proofing the menu for the health-conscious, GLP-1 consumer.